Acta Med. 2005, 48: 91-94
https://doi.org/10.14712/18059694.2018.38
Bone Marrow Necrosis: A Rare Complication of Herbal Treatment with Hypericum Perforatum (St. John’s Wort)
References
1. Am J Clin Pathol 2003; 120(1):127–37.
< A. Review of abnormal laboratory test results and toxic effects due to use of herbal medicines. https://doi.org/10.1309/P024K7VRDDPJCTVN>
2. Can J Clin Pharmacol 2003; 10(3):114–8.
AH, Walker SE. Analysis of the hypericin and pseudohypericin content of commercially available St. John’s wort preparations.
3. Oral Surg Oral Med Oral Pathol 1993; 75:443–51.
JB, Sharlock CH, Wolber RA. Oral manifestations of cytomegalovirus infection.
4. J Am Acad Child Adolesc Psychiatry 2003: 42(8):941–9.
RL, McNamara NK, O’Riordan MA et al. An open label pilot study of St. John’s wort in juvenile depression.
5. Crit Care Med 2000 Sep; 28(9):3341–5.
< F, Toledano B, Champagne J, Lacroix J. Reactive hemophagocytic syndrome presenting as a component of multiple organ dysfunction syndrome. https://doi.org/10.1097/00003246-200009000-00038>
6. Fytoterapia 2002; 73(4):300–4.
< S, Ohlendorf B, Johnson I. The genus Hypericum a valuable resource of anti-staphylococcal leads. https://doi.org/10.1016/S0367-326X(02)00082-5>
7. Haematologica 2002; 87(1):ECR01.
N, Rios E, Martin-Noya A, Rodriguez JM. Thrombotic thrombocytopenic purpura and bone marrow necrosis as a complication of gastric neoplasm.
8. Eur Arch Psychiatry Clin Neurosci 2003; 253(3):113–4.
< RK, Moller HJ. St. John’s wort. An option for the primary care treatment depressive patients. https://doi.org/10.1007/s00406-003-0417-6>
9. Rev Med Interne 1993; 14:958.
< M, Rigal-Huguet F, Moreau A et al. Bone marrow necrosis in malignant hemopathies. 7 cases. https://doi.org/10.1016/S0248-8663(05)80076-1>
10. Eur J Biopharm 2003; 56(1):121–32.
< K, Reichling J, Bommer S et al. Hyperforin a constituent of St. John’s wort (Hypericum perforatum L) extract induces apoptosis by triggering activation of caspases and with hypericin synergistically exerts cytotoxicity towards human malignant cell lines. https://doi.org/10.1016/S0939-6411(03)00046-8>
11. Cancer 2000; 88:1769–80.
< AM, Offner FC, Van Hove WZ. Bone marrow necrosis. https://doi.org/10.1002/(SICI)1097-0142(20000415)88:8<1769::AID-CNCR3>3.0.CO;2-H>
12. JAMA 2003; 290(11):1500–4.
< JS, Donovan JL, DeVane CL et al. Effects of St. John’s wort drug metabolism by induction of cytochrome P450 3A4 enzyme. https://doi.org/10.1001/jama.290.11.1500>
13. J Ethnopharmacol 2003 Jul, 87(1):89–92.
< A, Konyalioglu S, Bas M, Meral GE. The in vitro effects of Hypericum species on human leukocyte myeloperoxidase activity. https://doi.org/10.1016/S0378-8741(03)00117-X>
14. Am J Hematol 2002, 70:300–305.
< S, Ergin M, Baslamisli F, et al. Bone marrow necrosis: clinicopathologic analysis of 20 cases and review of the literature. https://doi.org/10.1002/ajh.10114>
15. Clin Rheumatol 1998, 17:219–22.
< RM, Vellose ER, Menezes Y, et al. Bone marrow findings in systemic lupus erythematosus patients with peripheral cytopenias. https://doi.org/10.1007/BF01451051>
16. Phytother Res 1999 Jun, 13(4):355–7.
< A, Jones BM, Erturk M. Antimicrobial activity of extracts from the cell cultures of some Turkish medicinal plants. https://doi.org/10.1002/(SICI)1099-1573(199906)13:4<355::AID-PTR454>3.0.CO;2-E>
17. Biol Pharm Bull 2002 Oct, 25(10):1320–3.
< P, Fernandes E, Carvalho F et al. Antioxidant activity of Hypericum androsaemum infusion: scavenging activity against superoxide radical, hydroxyl radical and hypochlorous acid. https://doi.org/10.1248/bpb.25.1320>
18. Biol Chem 2004 Dec, 385(12):1197–202.
< C, Wirleitner B, Schroecksnadel K, Schennach H, Fuchs D. St. John’s wort (Hypericum perforatum L) counteracts cytokine-induced tryptophan catabolism in vitro. https://doi.org/10.1515/BC.2004.155>
19. J Ethnopharmocol 1999 Sep, 66(3):289–93.
< E, Gurbuz I, Shibata H. Screening of Turkish anti-ulcerogenic folk remedies for anti-Helicobacter pylori activity. https://doi.org/10.1016/S0378-8741(98)00219-0>